Two Sigma Securities’s Cellyan Biotechnology HKPD Stock Holding History

Two Sigma Securities’s Portfolio HKPD Stock Details HKPD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-10,329	Closed	-$13.2K	–	2135
2025 Q2	$13.2K	Buy	+10,329	New	+$12.8K	﹤0.01%	1282

Other funds holding HKPD

Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Two Sigma Securities's HKPD Position: Q3 2025 in Review

Two Sigma Securities sold out of Cellyan Biotechnology (HKPD) in Q3 2025, closing a stake of 10,329 shares — an estimated $13.2K sold.

Two Sigma Securities first reported a position in HKPD in Q2 2025 and held it in 1 quarter. The position peaked at $13.2K in Q2 2025. 2 funds tracked by Wall St. Rank hold HKPD as of Q3 2025.

Two Sigma Securities reported no remaining Cellyan Biotechnology position as of Q3 2025 after selling out during the quarter.
Two Sigma Securities sold 10,329 Cellyan Biotechnology shares in Q3 2025, an estimated $13.2K.
Two Sigma Securities first reported a position in Cellyan Biotechnology in Q2 2025 and held it in 1 quarter.
Two Sigma Securities's Cellyan Biotechnology position peaked at $13.2K in Q2 2025.
2 funds tracked by Wall St. Rank held Cellyan Biotechnology as of Q3 2025.

Based on Two Sigma Securities's 13F filing for Q3 2025, filed 14 Nov 2025.